Central South University: Schizophrenia trials
The registry lists 30 Schizophrenia studies with Central South University as lead sponsor. 9 are open to participants now and 0 have results posted.
Phase 2 2Phase 3 2Phase 4 5No phase 21(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Individualized Sequential Accelerated Theta Burst Stimulation in Improving Cognitive Function in SchizophreniaNot yet recruitingNCT07806877Not applicable
- tACS for Working Memory in SchizophreniaRecruitingNCT07701343Not applicable
- TIS for Improving Cognitive Impairment in SchizophreniaRecruitingNCT07647380Not applicable
- Brain Network Mechanisms of Cognitive Impairments in Major Psychiatric Disorders and Their Clinical ApplicationsNot yet recruitingNCT07444463Not applicable
- Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia PatientsRecruitingNCT07045142Phase 3
- Immunoinflammatory State Detection and Multimodal Brain Imaging and Electrophysiologic Changes in SchizophreniaRecruitingNCT06673966
- nTMS for Negative Symptom in SchizophreniaRecruitingNCT06642675Not applicable
- Establishing a Clinical Database and Biobank for Schizophrenia：A Cohort StudyRecruitingNCT06123897
- iTBS for Increased Appetite Induced by AntipsychoticsRecruitingNCT05783063Not applicable
- TIS for Improving Cognitive Impairment Associated With SchizophreniaCompletedNCT07446478Not applicable
- Metformin Treatment on Cognitive Impairment of SchizophreniaCompletedNCT05838573Phase 3
- iTBS Can Increase Frontal Dopamine Release in PET Dopamine Imaging.Status unknownNCT05448430Not applicable
- Accelerated cTBS on Metabolic Dysfunction in People With SchizophreniaStatus unknownNCT05358899Not applicable
- iTBS on Negative Symptoms and Cognitive Function in SchizophreniaCompletedNCT05137158Not applicable
- cTBS on First-episode Drug Naive Patients With SchizophreniaStatus unknownNCT05086133Not applicable
- Resting State Electroencephalogram for Psychotic DisordersStatus unknownNCT05065489
- A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in SchizophreniaCompletedNCT05039489Not applicable
- rTMS on Appetite and Cognitive Function in SchizophreniaStatus unknownNCT04714970Not applicable
- A 6-month Study to Evaluate Sulforaphane Effects in Schizophrenia PatientsCompletedNCT04521868Phase 2
- Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic PatientsCompletedNCT03451734
- A 12-weeks Study to Evaluate the Dietary Fiber and Probiotics Treatment in Prevention and Intervention of Weight-gain and Cognitive Impairment of Schizophrenia or Bipolar DisorderCompletedNCT03379597Not applicable
- Metformin Treatment on Cognitive Impairment of Schizophrenia Co-morbid Metabolic SyndromeStatus unknownNCT03271866Not applicable
- A 6-month Study to Evaluate Sulforaphane add-on Effects in Treatment of SchizophreniaCompletedNCT02880462Phase 2
- The Mechanism of TCF7L2 and SLC30A8 on Antipsychotic-induced Metabolic SyndromeStatus unknownNCT02093858
- The Study of Minocycline for Negative and Cognitive Symptoms in SchizophreniaCompletedNCT01493622Phase 4
- A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in SchizophreniaStatus unknownNCT01490567Phase 4
- Effects of Exposed to Antipsychotics Throughout Pregnancy on Infants Development: A Prospective StudyCompletedNCT01479400
- Efficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol Intramuscular (IM) Injection for Treatment of Acute Psychotic Agitation in SchizophreniaCompletedNCT00859872Phase 4
- Effectiveness of Antipsychotic Combination With Psychosocial Intervention on Outcome of Patients With SchizophreniaCompletedNCT00654576Phase 4
- Identification and Treatment of the Liability to Develop SchizophreniaStatus unknownNCT00305474Phase 4